Evaluation of Safety Profile of Yellow Fever Vaccine in Healthy Indian Travellers: A Prospective Observational Study

Safety of yellow fever vaccine in Indian travellers

“…The increase in the number of travellers from India to YF endemic regions for various reasons has led to a rise in the demand for vaccination in India. Tiwari et al 6 in their pilot study on a limited number of travellers have confirmed the safety and recommended similar study in a larger sample to report the rare adverse drug reactions (ADR). This study was carried out to determine the safety and tolerability of YF vaccine in healthy Indian travellers.…”

“…The YF vaccine Stamaril ® (Sanofi-Pasteur, France) consisting of a live attenuated strain of YF virus (17 D-20 strain) was used in the study. Briefly, the travellers were followed for the occurrence of fever, malaise and myalgia, headache, nausea, vomiting, abdominal pain, diarrhoea, urticaria, local reaction and any other serious adverse event, on days 7 and 14, telephonically, post vaccination 6 . According to the Centers for Disease Control and Prevention (CDC), the incubation period of the AE due to YF varied from 1 to 10 days 7 .…”

Knowledge and attitude of Indian expatriate working at Gondar, Ethiopia regarding yellow fever vaccination: a survey

“…6 Every year a large number of Indians move to endemic regions and get vaccinated for yellow fever. 7 Till now, there is no case of yellow fever reported in India. As yellow fever is not endemic to India, so it is fair to understand the Indian expatriates being unaware of it.…”